Incidence, management and outcomes of arterial and venous thrombosis after chimeric antigen receptor modified T cells for B cell lymphoma and multiple myeloma. uri icon

authors

  • Anna Parks, MD
  • Kambhampati, Swetha
  • Fakhri, Bita
  • Andreadis, Charalambos
  • Gray, Lissa
  • Wong, Sandy W
  • Shah, Nina
  • Margaret C. Fang, MD, MPH

publication date

  • January 1, 2020